As of 2025-08-12, the Fair Value of Alliance Pharma PLC (APH.L) is -9.75 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 64.70 GBP, the upside of Alliance Pharma PLC is -115.07%.
With the market price of 64.70 GBP and our fair value calculation, Alliance Pharma PLC (APH.L) is not a good investment. Investing in APH.L stocks now will result in a potential loss of 115.07%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 8.03 | 7.32 | -21.21 | -33.14 | -10.73 | -9.95 |
| YoY growth | -67.90% | -8.82% | -389.77% | -56.24% | 67.62% | -91.02% |
| Market Cap (mil) | 355.92 |
| P/E | |
| Forward P/E |
| EPS | -1.95 |
| Avg earnings growth rate | -91.02% |
| TTM earnings | -10.73 |